#nephjc — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #nephjc, aggregated by home.social.
-
Reuse, learn, disseminate
But please credit when reusing material
www.nephjc.com/news/givemes...
#NephJC #MedEd #FOAMed
Credit Where Credit is Due — N... -
Reuse, learn, disseminate
But please credit when reusing material
www.nephjc.com/news/givemes...
#NephJC #MedEd #FOAMed
Credit Where Credit is Due — N... -
Got my copy for the #NephJC summer book club!
www.goodreads.com/book/show/57... -
Also read @[email protected] #NephJC shorts on the two accompanying papers
www.nephjc.com/news/2026/7/...
Finerenone across the proteinu... -
The #NephJC interns @[email protected] and @[email protected] dissect the FINDCKD study from @[email protected] et al
www.nephjc.com/news/2026/7/...
Beyond Diabetic Kidney Disease... -
Trutakna (what a strange name) aka atacicept (pronounced attack-e-sept) approved by FDA based on ORIGIN for IgAN
www.fda.gov/drugs/news-e...
#NephJC coverage of the trial www.nephjc.com/news/atacice...
Podcast www.nephjc.com/freelyfilter... -
A #NephJC short of the telitacicept trial from @[email protected]
www.nephjc.com/news/2026/sh...
IMO the exciting part of the early signal of GFR stabilization - if this is recapitulated with atacicept and sibeprelimab - then we can truly say IgAN remission is here and achievable
NephJC Short: When BAFF Meets ... -
Did a little Masters hooding ceremony with my Division this morning and got hooded by my longtime mentor, Dr. Mike Hutchens. Proudly Dr. Jess Hebert, PhD, MCR! Thank you, OHSU OCTRI and @[email protected]! #Kidney #NephJC
-
Did a little Masters hooding ceremony with my Division this morning and got hooded by my longtime mentor, Dr. Mike Hutchens. Proudly Dr. Jess Hebert, PhD, MCR! Thank you, OHSU OCTRI and @[email protected]! #Kidney #NephJC
-
A competitor for rilparencel?
https://www.kireports.org/article/S2468-0249(26)02860-3/fulltext?rss=yes in KIR
Just as the effective pharmacotherapies for DKD are coming online 😎
#NephJC discussion of rilparencel: https://www.nephjc.com/news/rilprencel-react
-
A competitor for rilparencel?
https://www.kireports.org/article/S2468-0249(26)02860-3/fulltext?rss=yes in KIR
Just as the effective pharmacotherapies for DKD are coming online 😎
#NephJC discussion of rilparencel: https://www.nephjc.com/news/rilprencel-react
-
A competitor for rilparencel?
https://www.kireports.org/article/S2468-0249(26)02860-3/fulltext?rss=yes in KIR
Just as the effective pharmacotherapies for DKD are coming online 😎
#NephJC discussion of rilparencel: https://www.nephjc.com/news/rilprencel-react
-
A competitor for rilparencel? www.kireports.org/article/S246... in KIR Just as the effective pharmacotherapies for DKD are coming online 😎 #NephJC discussion of rilparencel: www.nephjc.com/news/rilpren...
Randomized Controlled Clinical... -
A competitor for rilparencel?
https://www.kireports.org/article/S2468-0249(26)02860-3/fulltext?rss=yes in KIR
Just as the effective pharmacotherapies for DKD are coming online 😎
#NephJC discussion of rilparencel: https://www.nephjc.com/news/rilprencel-react
-
A competitor for rilparencel?
https://www.kireports.org/article/S2468-0249(26)02860-3/fulltext?rss=yes in KIR
Just as the effective pharmacotherapies for DKD are coming online 😎
#NephJC discussion of rilparencel: https://www.nephjc.com/news/rilprencel-react
-
recording an episode of @[email protected] with some filtrates and special guest Carla Nester from U IOwa #NephJC
-
Announcing the #NephJC internship class
https://www.nephjc.com/news/2025/6/21/nephjc-internship-2026
-
Announcing the #NephJC internship class
https://www.nephjc.com/news/2025/6/21/nephjc-internship-2026
-
Announcing the #NephJC internship class
https://www.nephjc.com/news/2025/6/21/nephjc-internship-2026
-
Announcing the #NephJC internship class
NephJC Internship 2026-2027 — ... -
Announcing the #NephJC internship class
https://www.nephjc.com/news/2025/6/21/nephjc-internship-2026
-
Announcing the #NephJC internship class
https://www.nephjc.com/news/2025/6/21/nephjc-internship-2026
-
The #NephJC summary of the hydralazine doesn’t cause that much vasculitis JNO paper https://www.nephjc.com/news/hydralazine-anca-vasculitis
-
The #NephJC summary of the hydralazine doesn’t cause that much vasculitis JNO paper https://www.nephjc.com/news/hydralazine-anca-vasculitis
-
The #NephJC summary of the hydralazine doesn’t cause that much vasculitis JNO paper https://www.nephjc.com/news/hydralazine-anca-vasculitis
-
The #NephJC summary of the hydralazine doesn’t cause that much vasculitis JNO paper https://www.nephjc.com/news/hydralazine-anca-vasculitis
-
The #NephJC summary of the hydralazine doesn’t cause that much vasculitis JNO paper https://www.nephjc.com/news/hydralazine-anca-vasculitis
-
A. I am not convinced how a 3X effect in crude becomes a 1.2x effect after PS weighting black box B. As we say in the summary, there are no good reasons to use hydralazine anyways. So small risk:zero benefit = infinite risk:benefit ratio. #NephJC
-
The #NephJC summary of the hydralazine doesn’t cause that much vasculitis JNO paper
Why-dralazine?! Population ris... -
The #NephJC crew cover the simultaneous publications from the #ISNWCN www.nephjc.com/news/isnwcn-... Iptacopan IN NEJM Atrasentan with Flozin in JASN Age/Sex interactions from CONFIDENCE in NDT Mediation analysis from CONFIDENCE also in JASN
NephJC Covers LBCTs at the Wor... -
The #NephJC crew cover the simultaneous publications from the #ISNWCN https://www.nephjc.com/news/isnwcn-yokohama
Iptacopan IN NEJM
Atrasentan with Flozin in JASN
Age/Sex interactions from CONFIDENCE in NDT
Mediation analysis from CONFIDENCE also in JASN -
The #NephJC crew cover the simultaneous publications from the #ISNWCN https://www.nephjc.com/news/isnwcn-yokohama
Iptacopan IN NEJM
Atrasentan with Flozin in JASN
Age/Sex interactions from CONFIDENCE in NDT
Mediation analysis from CONFIDENCE also in JASN -
The #NephJC crew cover the simultaneous publications from the #ISNWCN https://www.nephjc.com/news/isnwcn-yokohama
Iptacopan IN NEJM
Atrasentan with Flozin in JASN
Age/Sex interactions from CONFIDENCE in NDT
Mediation analysis from CONFIDENCE also in JASN -
The #NephJC crew cover the simultaneous publications from the #ISNWCN https://www.nephjc.com/news/isnwcn-yokohama
Iptacopan IN NEJM
Atrasentan with Flozin in JASN
Age/Sex interactions from CONFIDENCE in NDT
Mediation analysis from CONFIDENCE also in JASN -
The #NephJC crew cover the simultaneous publications from the #ISNWCN https://www.nephjc.com/news/isnwcn-yokohama
Iptacopan IN NEJM
Atrasentan with Flozin in JASN
Age/Sex interactions from CONFIDENCE in NDT
Mediation analysis from CONFIDENCE also in JASN -
Applications are open for the next class of the #NephJC internship Apply here www.nephjc.com/news/nephjc-... or scan the QR code #ISNWCN
-
But why not use Rituximab instead www.nephjc.com/news/2025/11... #NephJC #ISNWCN
Kidney Week in Houston: Day 3 ... -
Should I write an entire parody album about the parts of the kidney, yes/super yes Brought to you by changing "Age of Aquarius" to "Macrophage of Glomerulus" #kidneycrew #nephjc
two red kidneys with arms and ... -
Should I write an entire parody album about the parts of the kidney, yes/super yes Brought to you by changing "Age of Aquarius" to "Macrophage of Glomerulus" #kidneycrew #nephjc
two red kidneys with arms and ... -
Yet another ddAVP trial for kidney biopsies with neutral results
https://academic.oup.com/ckj/advance-article/doi/10.1093/ckj/sfag083/8516492
In Clinical Kidney Journal
Previous #NephJC discussion: https://www.nephjc.com/news/ddavp
-
Yet another ddAVP trial for kidney biopsies with neutral results
https://academic.oup.com/ckj/advance-article/doi/10.1093/ckj/sfag083/8516492
In Clinical Kidney Journal
Previous #NephJC discussion: https://www.nephjc.com/news/ddavp
-
Yet another ddAVP trial for kidney biopsies with neutral results
https://academic.oup.com/ckj/advance-article/doi/10.1093/ckj/sfag083/8516492
In Clinical Kidney Journal
Previous #NephJC discussion: https://www.nephjc.com/news/ddavp
-
Yet another ddAVP trial for kidney biopsies with neutral results academic.oup.com/ckj/advance-... In Clinical Kidney Journal Previous #NephJC discussion: www.nephjc.com/news/ddavp
Bleeding prevention with desmo... -
Yet another ddAVP trial for kidney biopsies with neutral results
https://academic.oup.com/ckj/advance-article/doi/10.1093/ckj/sfag083/8516492
In Clinical Kidney Journal
Previous #NephJC discussion: https://www.nephjc.com/news/ddavp
-
Yet another ddAVP trial for kidney biopsies with neutral results
https://academic.oup.com/ckj/advance-article/doi/10.1093/ckj/sfag083/8516492
In Clinical Kidney Journal
Previous #NephJC discussion: https://www.nephjc.com/news/ddavp
-
Swapnil Hiremath #NephJC Sorry just returning from our #NephMadness party - joining in late
-
Can an ineffective intervention be cost-effective? Cristina Popa breaks down the latest low protein diet proponents insipid attempt for a #NephJC Shorts www.nephjc.com/news/2026/2/...
Dialysis delay at what cost? P... -
Can an ineffective intervention be cost-effective? Cristina Popa breaks down the latest low protein diet proponents insipid attempt for a #NephJC Shorts www.nephjc.com/news/2026/2/...
Dialysis delay at what cost? P... -
Can an ineffective intervention be cost-effective?
Cristina Popa breaks down the latest low protein diet proponents insipid attempt for a #NephJC Shorts
-
Can an ineffective intervention be cost-effective?
Cristina Popa breaks down the latest low protein diet proponents insipid attempt for a #NephJC Shorts
-
Can an ineffective intervention be cost-effective?
Cristina Popa breaks down the latest low protein diet proponents insipid attempt for a #NephJC Shorts
-
Can an ineffective intervention be cost-effective?
Cristina Popa breaks down the latest low protein diet proponents insipid attempt for a #NephJC Shorts
-
Can an ineffective intervention be cost-effective?
Cristina Popa breaks down the latest low protein diet proponents insipid attempt for a #NephJC Shorts
-
There was some intriguing data for HIF in inflammation or high hepcidin states - but I haven’t seen good data - I guess the field has moved to trying Ziktekevimab etc instead? #NephJC
-
To me, it is difficult to justify a placebo controlled trial without proper guardrails (not transfusion - rescue ESA maybe) which was done in the non-dialysis trials In dialysis patients with anemia, how do you justify withholding ESA (which is standard of care)? #NephJC
-
Isn’t it cool that the iron in our bodies came from a 5 billion year old supernova? www.esa.int/ESA_Multimed... We are…..literally stardust (🎤 drop) #NephJC
Supernovas blast iron into int...